Home›Stock Screener›Lincoln Pharmaceuticals›P/E Ratio

Lincoln Pharmaceuticals P/E Ratio

Current P/E Ratio
12.09
Low Valuation
Low - May indicate good value opportunity

Lincoln Pharmaceuticals P/E ratio. Lincoln Pharmaceuticals (LINCOLN) P/E ratio is 12.09 (Low), EPS (TTM) ₹43.88, current price ₹567.20 on NSE vs historical average P/E of 11.15 (60.0th percentile) — Low - May indicate good value opportunity. For live price, revenue and the complete fundamental profile, see LINCOLN share price screener.

Current Valuation Metrics

P/E Ratio 12.09
Current Price ₹567.20
EPS (TTM) ₹43.88
Exchange NSE

Valuation Signal

Signal Fairly Valued
Historical Avg 11.15
Historical Range 6.87 - 19.54
Percentile 60.0%

Sector Context

Sector Average 56.42
Sector Median 32.5
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹39.66
Mar 2026 ₹5.81
Jun 2026 ₹18.09

LINCOLN P/E Ratio — Valuation Signal & Historical Context

Lincoln Pharmaceuticals P/E 12.09 vs historical average 11.15, range 6.87–19.54 — signal: Fairly Valued. Examine LINCOLN quarterly trends for recent quarterly revenue, profit and EPS trends.

  • Stock appears undervalued with PE of 12.09, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 56.42

Lincoln Pharmaceuticals P/E Ratio Historical Trend

LINCOLN annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 12.09 vs historical average 11.15. Also explore Lincoln Pharmaceuticals share price performance to track price trends across different timeframes.

LINCOLN Historical P/E Ratio — EPS, Year-End Price & Valuation

Lincoln Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 19.54 43.86 ₹857.05 NSE Moderate
2024 14.38 44.62 ₹641.45 NSE Low
2023 8.26 43.57 ₹360.05 NSE Low
2022 10.2 35.62 ₹363.45 NSE Low
2021 6.87 35.43 ₹243.25 NSE Low
2020 6.99 29.29 ₹204.85 NSE Low
2019 8.87 25.5 ₹226.15 NSE Low
2018 10.13 23.52 ₹238.35 NSE Low
2017 12.87 14.56 ₹187.35 NSE Low
2016 13.42 18.14 ₹243.45 NSE Low

LINCOLN vs Healthcare Peers — P/E Ratio Comparison

Lincoln Pharmaceuticals P/E 12.09 vs Healthcare average 56.42, median 32.5 — range 2.04–740.29.

Sector Average
56.42
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low